Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.66 USD | 0.00% | -8.33% | -86.54% |
Mar. 15 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
Mar. 14 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
Evolution of the average Target Price on Quoin Pharmaceuticals, Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Quoin Pharmaceuticals, Ltd.
Maxim | |
Ladenburg Thalmann | |
JMP Securities | |
Alliance Global Partners |
EPS Revisions
- Stock Market
- Equities
- QNRX Stock
- Consensus Quoin Pharmaceuticals, Ltd.